BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 30918026)

  • 1. Protein Z-dependent protease inhibitor (ZPI) is a physiologically significant inhibitor of prothrombinase function.
    Huang X; Swanson R; Kroh HK; Bock PE
    J Biol Chem; 2019 May; 294(19):7644-7657. PubMed ID: 30918026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering a protein Z-dependent protease inhibitor (ZPI) mutant as a novel antagonist of ZPI anticoagulant function for hemophilia treatment.
    Huang X
    J Thromb Haemost; 2019 Oct; 17(10):1655-1660. PubMed ID: 31423718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the protein Z-dependent protease inhibitor.
    Han X; Fiehler R; Broze GJ
    Blood; 2000 Nov; 96(9):3049-55. PubMed ID: 11049983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basis for the specificity and activation of the serpin protein Z-dependent proteinase inhibitor (ZPI) as an inhibitor of membrane-associated factor Xa.
    Huang X; Dementiev A; Olson ST; Gettins PG
    J Biol Chem; 2010 Jun; 285(26):20399-409. PubMed ID: 20427285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic characterization of the protein Z-dependent protease inhibitor reaction with blood coagulation factor Xa.
    Huang X; Swanson R; Broze GJ; Olson ST
    J Biol Chem; 2008 Oct; 283(44):29770-83. PubMed ID: 18768472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid oxidation inactivates the anticoagulant function of protein Z-dependent protease inhibitor (ZPI).
    Huang X; Liu B; Wei Y; Beyea R; Yan H; Olson ST
    J Biol Chem; 2017 Sep; 292(35):14625-14635. PubMed ID: 28717005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thermodynamic and kinetic characterization of the protein Z-dependent protease inhibitor (ZPI)-protein Z interaction reveals an unexpected role for ZPI Lys-239.
    Huang X; Zhou J; Zhou A; Olson ST
    J Biol Chem; 2015 Apr; 290(15):9906-18. PubMed ID: 25713144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the protein Z-dependent protease inhibitor interactive-sites of protein Z.
    Qureshi SH; Lu Q; Manithody C; Yang L; Rezaie AR
    Biochim Biophys Acta; 2014 Sep; 1844(9):1631-7. PubMed ID: 24960590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor V has an anticoagulant cofactor activity that targets the early phase of coagulation.
    Santamaria S; Reglińska-Matveyev N; Gierula M; Camire RM; Crawley JTB; Lane DA; Ahnström J
    J Biol Chem; 2017 Jun; 292(22):9335-9344. PubMed ID: 28420729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressing protein Z-dependent inhibition of factor Xa improves coagulation in hemophilia A.
    Girard TJ; Lasky NM; Grunz K; Broze GJ
    J Thromb Haemost; 2019 Jan; 17(1):149-156. PubMed ID: 30451376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin activation of protein Z-dependent protease inhibitor (ZPI) allosterically blocks protein Z activation through an extended heparin-binding site.
    Huang X; Swanson R; Olson ST
    J Biol Chem; 2022 Jun; 298(6):102022. PubMed ID: 35551912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein Z/protein Z-dependent protease inhibitor system in loco in human gastric cancer.
    Sierko E; Wojtukiewicz MZ; Zimnoch L; Tokajuk P; Ostrowska-Cichocka K; Kisiel W
    Ann Hematol; 2014 May; 93(5):779-84. PubMed ID: 24158387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin is a major activator of the anticoagulant serpin, protein Z-dependent protease inhibitor.
    Huang X; Rezaie AR; Broze GJ; Olson ST
    J Biol Chem; 2011 Mar; 286(11):8740-51. PubMed ID: 21220417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residues of the 39-loop restrict the plasma inhibitor specificity of factor IXa.
    Yang L; Rezaie AR
    J Biol Chem; 2013 May; 288(18):12692-8. PubMed ID: 23530052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of specificity of factor xa interaction with its physiological inhibitors.
    Rezaie AR
    Mini Rev Med Chem; 2006 Aug; 6(8):859-65. PubMed ID: 16918492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of factor Xa residues critical for interaction with protein Z-dependent protease inhibitor: both active site and exosite interactions are required for inhibition.
    Rezaie AR; Manithody C; Yang L
    J Biol Chem; 2005 Sep; 280(38):32722-8. PubMed ID: 16079143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated protein C, protein S, and tissue factor pathway inhibitor cooperate to inhibit thrombin activation.
    Li X; Song X; Mahmood DFD; Sim MMS; Bidarian SJ; Wood JP
    Thromb Res; 2023 Oct; 230():84-93. PubMed ID: 37660436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of protein Z-dependent inhibitor complex shows how protein Z functions as a cofactor in the membrane inhibition of factor X.
    Wei Z; Yan Y; Carrell RW; Zhou A
    Blood; 2009 Oct; 114(17):3662-7. PubMed ID: 19528533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein Z-dependent protease inhibitor binds to the C-terminal domain of protein Z.
    Rezaie AR; Bae JS; Manithody C; Qureshi SH; Yang L
    J Biol Chem; 2008 Jul; 283(29):19922-6. PubMed ID: 18502758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory properties of the P1 Tyr variant of antithrombin.
    Yang L; Manithody C; Qureshi SH; Rezaie AR
    Biochemistry; 2010 Mar; 49(12):2680-6. PubMed ID: 20184328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.